Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Chinese Oncology》 2012-01
Add to Favorite Get Latest Update

A Clinical Study of Pemetrexed Combined with Cisplatin in the Treatment for Re-treated Advanced Breast Cancer

XU Zheng-yang,YANG Hui,YUAN Guang-bo,et al.(Yinzhou People's Hospital,Ningbo 315040,China)  
[Purpose] To evaluate the efficacy and side effects of pemetrexed combined with cisplatin in the treatment for re-treated advanced breast cancer.[Methods] From Jan 2008 to Jan 2011,38 patients with re-treated advanced breast cancer pathologically proven who received combination of pemetrexed and cisplatin regimen.The efficacy and side effects were evaluated.[Results] All of 38 patients were evaluable for response.The response rate(RR) and disease control rate(DCR) were 39.5% and 73.7% respectively.The median time to progress(TTP) was 5 months and the median overall survival(OS) was 12 months.The main side effects were skin rash,mucositis,gastrointestinal toxicity and myelosuppression.[Conclusion] Pemetrexed combined with cisplatin in the treatment for re-treated advanced breast cancer is effective with mild toxicity.It deserves the clinical expansion and further exploration.
【CateGory Index】: R737.9
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved